GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Carescape Canvas patient monitoring platform.
Carescape Canvas offers precise, flexible patient care. Together with Carescape One, it makes up part of an adaptable ecosystem set for scaling up and scaling down monitoring capabilities. This comes based on the acuity of each individual patient. The platform delivers monitoring on a standardized platform that drives enterprise efficiency and ease of service.
A FlexAcuity solution, Carescape Canvas features smart parameter technology for patients at all levels of acuity. The platform offers flexibility, standardization and ease of use. It leverages micromodules that connect with standardized medical USB technology. Adding or disconnecting cables equipped for various configuration enables more efficient care based on patient needs, GE HealthCare said.
With flexible, easy-to-configure software and interchangeable frames, it enables quick redeployment of devices across hospitals, too.
“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, GM, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. Carescape Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”
More about the latest GE HealthCare patient monitoring offering
GE HealthCare developed and tested Carescape Canvas with the rest of its ecosystem. That includes current devices and prior versions used across hospitals today. Backward compatibility enables healthcare systems to upgrade to the latest capabilities at their own pace, the company said.
Additional development features included sustainability. GE HealthCare developed Carescape Canvas with a 53% reduction in packaging volume. It also offers a 48% reduction in packaging weight compared to a previous generation monitor and a 25% energy consumption reduction against prior models. GE HealthCare’s Helsinki, Finland site utilizes 100% renewable wind electricity to manufacture the systems, too.
Carescape Canvas initially received European approval in June 2022.
